Iron showdown: IV or pills for anemia in pregnancy?
NCT ID NCT07384663
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This completed Phase 1 trial tested whether a single IV dose of ferric carboxymaltose works better than daily oral polysaccharide iron complex capsules for treating iron deficiency anemia in pregnant women. 112 women in their second trimester with low hemoglobin levels took part. The goal was to see which approach raises blood hemoglobin to normal levels more effectively after 4 weeks.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Iron (ferric carboxymaltose and polysaccharide iron complex)
- What this could lead to
- If IV iron works better, it could offer a faster, more effective way to treat anemia in pregnancy, improving health for both mother and baby.
- What could go wrong
- This is a small, early-phase trial with only 112 participants, so results may not apply to all pregnant women. IV iron also carries a small risk of allergic reactions.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for IRON DEFICIENCY ANAEMIA IN CHILDBIRTH are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Doctors Hospital and Medical Centre Lahore
Lahore, 54000, Pakistan